Cargando…
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver
The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5–20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually hi...
Autores principales: | Klein, Kathrin, Winter, Stefan, Turpeinen, Miia, Schwab, Matthias, Zanger, Ulrich M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171976/ https://www.ncbi.nlm.nih.gov/pubmed/21918647 http://dx.doi.org/10.3389/fphar.2010.00129 |
Ejemplares similares
-
Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
por: Thomas, Maria, et al.
Publicado: (2015) -
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
por: Riedmaier, Stephan, et al.
Publicado: (2011) -
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
por: Zanger, Ulrich M., et al.
Publicado: (2013) -
Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
por: Zhang, J. E., et al.
Publicado: (2017) -
Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis
por: Heintze, Tamara, et al.
Publicado: (2021)